Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
Nousheen Samad1, Anas Younes21Division of Pharmacy, Pharmacy Clinical Programs, 2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract: Mantle cell lymphoma (MCL) is a rare and aggressive subtype of lymphoma associated with a poor prognosis....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-09-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/temsirolimus-in-the-treatment-of-relapsed-or-refractory-mantle-cell-ly-a5227 |